After a three-month trial, it took a jury seven full days to conclude that Theranos Inc. founder Elizabeth Holmes was guilty of four counts of fraud.

The startup world had been watching in suspense, but it was largely for the spectacle of it all — not because anyone thought the verdict would significantly change behavior in venture capital fundraising.

Holmes was convicted of defrauding investors in the blood-testing startup of hundreds of millions of dollars.